captopril has been researched along with Carcinoma, Hepatocellular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cai, Z; Liao, N; Liu, X; Wang, P; Wang, Y; Zeng, Y; Zhang, D; Zhao, B; Zhao, Q; Zheng, Y; Zhuang, Q | 1 |
Arora, G; Bandiera, S; Barrett, SC; Baumert, TF; Chung, RT; Crouchet, E; Del Zompo, F; Durand, SC; El Saghire, H; Felli, E; Fuchs, BC; Fujiwara, N; Ghoshal, S; Giannone, F; Hoshida, Y; Li, S; Lupberger, J; Oudot, MA; Pessaux, P; Pochet, N; Ponsolles, C; Qian, T; Rasha, FA; Schaeffer, E; Schuster, C; Slovic, N; Sojoodi, M; Tanabe, KK; Van Renne, N; Zhu, S | 1 |
Chen, IS; Chou, CT; Hao, LJ; Jan, CR; Kuo, CC; Liang, WZ; Liu, YY; Wang, JL | 1 |
3 other study(ies) available for captopril and Carcinoma, Hepatocellular
Article | Year |
---|---|
Remodeling Tumor-Associated Neutrophils to Enhance Dendritic Cell-Based HCC Neoantigen Nano-Vaccine Efficiency.
Topics: Animals; Captopril; Carcinoma, Hepatocellular; Dendritic Cells; Ferric Compounds; Liver Neoplasms; Mice; Neutrophils; Tumor Microenvironment | 2022 |
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carcinogenesis; Carcinoma, Hepatocellular; Chemoprevention; Disease Progression; ErbB Receptors; Liver Cirrhosis; Liver Neoplasms; Peptidyl-Dipeptidase A; Rats; Transcriptional Activation | 2022 |
Effect of Captopril on Ca²⁺ Homeostasis and Cell Viability in Human Hepatoma Cells.
Topics: Apoptosis; Calcium; Calcium Signaling; Captopril; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Homeostasis; Humans; Liver Neoplasms; Type C Phospholipases | 2018 |